nycomed news
Your Search Returned 51 tagged news reports
Orphan Drug Is Headed Back to Its Parent
Bristol :: VA :: USA | 2 months ago
Credibility
The biotech announced yesterday that it had reacquired the ex-North America rights to two drugs -- Revestive and Preotact -- that were licensed to Nycomed, which was subsequently acquired by Takeda Pharmaceutical ...Preotact is approved in Europe for
Tags:
Chinese company gets rights to anti-cancer drug
Guangzhou :: China | 5 months ago
Credibility
Boniva first launched on the Chinese market by Roche Shanghai in 2006 is the only third-generation diphosphonate with both an oral formulation and intravenous preparation. Antineoplastic drugs are used in chemotherapy to control or kill cancer cells.
Tags:
Swiss firm opens doors for Japanese
Bern :: Switzerland | 11 months ago
Credibility
Walk a few hundred metres from the train station in Schwarzenburg, a village in the alpine foothills southwest of Bern, and you arrive at the entrance to a Japanese company: Gilgen Door Systems. In the reception area is a piece of artwork
Tags:
Takeda Open to More Deals
Tōkyō :: Japan | 1 year ago
Credibility
We will be looking for those things that are a very good fit with what we have already put in place," Anna Protopapas, a corporate officer at Takeda who oversees the company's global M&A functions, said in a recent interview...Protopapas helped to
Tags:
Novartis Aquires Fougera In $1.5B Deal
Melville :: NY :: USA | 1 year ago
Credibility
announced Wednesday it would acquire Melville, N.Y.-based Fougera Pharmaceuticals Inc. for 1.5 billion in cash. The deal makes Sandoz, Novartis's generic pharmaceuticals division, the world's largest maker of generic dermatological drugs. Fougera's
Tags:
GlaxoSmithKline Antitrust Probe Dropped by EU Commission - Bloomberg
Brussels :: Belgium | 1 year ago
Credibility
The European Commission said it ended an antitrust probe into GlaxoSmithKline Plc (GSK) over possible collusion to keep cheaper copies of medicines off the market after a complaint against the company was withdrawn. The Commission examined whether
Tags:
EU Finds No Wrongdoing After Nycomed, AstraZeneca Probe - WSJ.com
Brussels :: Belgium | 1 year ago
Credibility
The European Commission said Thursday it has closed an antitrust investigation into possible deals between pharmaceutical companies AstraZeneca PLC (AZN) and Nycomed SCA after finding no wrongdoing. "The investigation focused on suspected individual
Tags:
Durect regains Posidur rights
Toronto :: Canada | over 1 year ago
Credibility
Posidur is a post-operative pain relief depot that utilizes Durect's patented Saber technology to deliver bupivacaine and is designed to provide up to three days of pain relief after surgery...Posidur is licensed to Hospira for commercialization in
Tags:
Takeda to pare workforce 9% to revive profit
Ōsaka :: Japan | over 1 year ago
Credibility
Takeda will cut 2,800 jobs, mainly in Europe and the U.S., to help yield net savings of about ¥130 billion by the year ending March 31, 2016, the Osaka-based company said Wednesday. Asia's biggest drug maker said costs associated with the plan will
Tags:
Takeda Announces Cuts
New York City :: NY :: USA | over 1 year ago
Credibility
More of them are in Europe than in the US (via the Nycomed acquisition), but there are hundreds of positions to be lost in this country, too. For now, the company seems to be just saying that they'll be in all parts of the organization, without much
Tags:
